Seyches, Nouvelle-Aquitaine, France
Leading the European BD sales team for development (preclinical safety, API and Drug Product manufacturing and clinical studies) services
Leading a team of 6 sales people selling discovery and development services across Europe. Personally selling the development services of the Evotec Group, which includes those marketed under the Aptuit brand. - Full suite of preclinical safety studies to GLP - API synthesis to cGMP including commercial license - Drug Product manufacture to cGMP, specialising in solid oral and inhaled products. Includes commercial manufacture - Clinical studies in healthy volunteers and patients Our other specialities include formulation, material science, DMPK/ADME, stability, bioanalysis and drug-abuse liability studies. Designated as the company's global business development expert for preclinical safety and clinical services.
Penman Consulting, certified to ISO9001 quality management, now employees 32 staff the U.K and Belgium. Our core services include Toxicology, Environmental Sciences, Product Stewardship & Regulatory Affairs, and software development. Rob is responsible for the leadership, development, and operations of Penman Consulting as well as managing the Lower Olefins and Aromatics Reach Consortium (http://loa-reach.com) with its 48 members and ca. 170 substances in 13 categories.
Envigo was formed by the acquisition of Harlan by HLS. Rob was managing the team of 7 business developers selling Envigo regulatory and testing services to chemical and crop protection clients in Europe.
Managing the team of business developers and strategic alliance managers looking after chemical clients in Europe